These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22222956)

  • 1. Can humanized mice reflect the complex pathobiology of HIV-associated neurocognitive disorders?
    Gorantla S; Gendelman HE; Poluektova LY
    J Neuroimmune Pharmacol; 2012 Jun; 7(2):352-62. PubMed ID: 22222956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humanized mouse models for HIV-1 infection of the CNS.
    Honeycutt JB; Sheridan PA; Matsushima GK; Garcia JV
    J Neurovirol; 2015 Jun; 21(3):301-9. PubMed ID: 25366661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanized mice: models for evaluating NeuroHIV and cure strategies.
    Honeycutt JB; Garcia JV
    J Neurovirol; 2018 Apr; 24(2):185-191. PubMed ID: 28831774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of HIV-associated disease of the central nervous system.
    Mallard J; Williams KC
    Handb Clin Neurol; 2018; 152():41-53. PubMed ID: 29604983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1-associated central nervous system dysfunction.
    Krebs FC; Ross H; McAllister J; Wigdahl B
    Adv Pharmacol; 2000; 49():315-85. PubMed ID: 11013768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Induced CNS Dysfunction: Current Overview and Research Priorities.
    Joseph J; Colosi DA; Rao VR
    Curr HIV Res; 2016; 14(5):389-399. PubMed ID: 27009096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rodent models for HIV-associated neurocognitive disorders.
    Gorantla S; Poluektova L; Gendelman HE
    Trends Neurosci; 2012 Mar; 35(3):197-208. PubMed ID: 22305769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency.
    Llewellyn GN; Alvarez-Carbonell D; Chateau M; Karn J; Cannon PM
    J Neurovirol; 2018 Apr; 24(2):192-203. PubMed ID: 29256041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis.
    Gorantla S; Makarov E; Finke-Dwyer J; Castanedo A; Holguin A; Gebhart CL; Gendelman HE; Poluektova L
    Am J Pathol; 2010 Dec; 177(6):2938-49. PubMed ID: 21088215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Signatures of HIV-1 Envelope Associated with HIV-Associated Neurocognitive Disorders.
    Evering TH
    Curr HIV/AIDS Rep; 2018 Feb; 15(1):72-83. PubMed ID: 29460224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanized Mouse Models for Human Immunodeficiency Virus Infection.
    Marsden MD; Zack JA
    Annu Rev Virol; 2017 Sep; 4(1):393-412. PubMed ID: 28746819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.
    Kramer-Hämmerle S; Rothenaigner I; Wolff H; Bell JE; Brack-Werner R
    Virus Res; 2005 Aug; 111(2):194-213. PubMed ID: 15885841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 infection and neurocognitive impairment in the current era.
    del Palacio M; Alvarez S; Muñoz-Fernández MÁ
    Rev Med Virol; 2012 Jan; 22(1):33-45. PubMed ID: 21990255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of HIV-1 pathogenesis using humanized mouse model].
    Sato K
    Uirusu; 2016; 66(1):91-100. PubMed ID: 28484185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection.
    Olesen R; Wahl A; Denton PW; Garcia JV
    J Reprod Immunol; 2011 Mar; 88(2):195-203. PubMed ID: 21256601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathogenesis of human immunodeficiency virus infection.
    Sillman B; Woldstad C; Mcmillan J; Gendelman HE
    Handb Clin Neurol; 2018; 152():21-40. PubMed ID: 29604978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of HIV clade differences on the onset and severity of HIV-associated neurocognitive disorders.
    Tyor W; Fritz-French C; Nath A
    J Neurovirol; 2013 Dec; 19(6):515-22. PubMed ID: 24129908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of HIV in the CNS: effects of antiretroviral therapy and the promise of non-antiretroviral therapeutics.
    Peluso MJ; Spudich S
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):353-62. PubMed ID: 25063356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When do models of NeuroAIDS faithfully imitate "the real thing"?
    Gelman BB; Endsley J; Kolson D
    J Neurovirol; 2018 Apr; 24(2):146-155. PubMed ID: 29256039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unravelling the triad of neuroinvasion, neurodissemination, and neuroinflammation of human immunodeficiency virus type 1 in the central nervous system.
    Calado M; Ferreira R; Pires D; Santos-Costa Q; Anes E; Brites D; Azevedo-Pereira JM
    Rev Med Virol; 2024 May; 34(3):e2534. PubMed ID: 38588024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.